Lihui Wang

1.1k total citations
32 papers, 864 citations indexed

About

Lihui Wang is a scholar working on Surgery, Molecular Biology and Physiology. According to data from OpenAlex, Lihui Wang has authored 32 papers receiving a total of 864 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Molecular Biology and 6 papers in Physiology. Recurrent topics in Lihui Wang's work include Autophagy in Disease and Therapy (4 papers), Salivary Gland Disorders and Functions (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Lihui Wang is often cited by papers focused on Autophagy in Disease and Therapy (4 papers), Salivary Gland Disorders and Functions (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Lihui Wang collaborates with scholars based in China, United States and Australia. Lihui Wang's co-authors include Chunfu Wu, Jingyu Yang, Wei Cui, Zhe‐Sheng Chen, Jingyu Wang, Hong Li, Yating Wang, Xue Xue, Yingxu Dong and Jie Li and has published in prestigious journals such as Journal of Medicinal Chemistry, Experimental Cell Research and European Journal of Pharmacology.

In The Last Decade

Lihui Wang

28 papers receiving 857 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lihui Wang China 14 308 171 134 122 120 32 864
Ji-Min Cao China 23 536 1.7× 102 0.6× 212 1.6× 146 1.2× 183 1.5× 68 1.5k
Rimpy Dhingra Canada 16 572 1.9× 115 0.7× 228 1.7× 59 0.5× 119 1.0× 25 1.0k
Ashutosh Shrivastava India 15 458 1.5× 114 0.7× 138 1.0× 98 0.8× 162 1.4× 61 1.1k
Lin Hou China 18 460 1.5× 207 1.2× 50 0.4× 99 0.8× 194 1.6× 67 1.0k
Qing Mei Wang United States 19 512 1.7× 215 1.3× 169 1.3× 74 0.6× 90 0.8× 49 1.3k
Ljubica Vučićević Serbia 21 642 2.1× 193 1.1× 327 2.4× 60 0.5× 145 1.2× 37 1.4k
Maja Misirkić Serbia 21 572 1.9× 207 1.2× 316 2.4× 54 0.4× 139 1.2× 34 1.3k
Saeed Rezapoor Iran 18 345 1.1× 131 0.8× 61 0.5× 188 1.5× 81 0.7× 22 998
Qingsong Wang China 16 386 1.3× 51 0.3× 184 1.4× 48 0.4× 91 0.8× 49 997

Countries citing papers authored by Lihui Wang

Since Specialization
Citations

This map shows the geographic impact of Lihui Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lihui Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lihui Wang more than expected).

Fields of papers citing papers by Lihui Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lihui Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lihui Wang. The network helps show where Lihui Wang may publish in the future.

Co-authorship network of co-authors of Lihui Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Lihui Wang. A scholar is included among the top collaborators of Lihui Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lihui Wang. Lihui Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhu, X. X., Jun Xie, Lihui Wang, et al.. (2024). Biomarkers of lymph node metastasis in colorectal cancer: update. Frontiers in Oncology. 14. 1409627–1409627. 2 indexed citations
3.
Li, Yeping, et al.. (2024). Effects of non‐pharmacological interventions on pain in wound patients during dressing change: A systematic review. Nursing Open. 11(2). e2107–e2107. 5 indexed citations
4.
Meng, Yangyang, Yidong Wang, Shaopeng Zhang, et al.. (2023). Novel 4-Arylindolines Containing a Pyrido[3,2-d]pyrimidine Moiety as the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction Inhibitors for Tumor Immunotherapy. Journal of Medicinal Chemistry. 66(17). 11815–11830. 6 indexed citations
5.
Min, Hua, et al.. (2023). The value of serum Lp-PLA2 combined with MPO in the diagnosis of cerebral infarction caused by large artery atherosclerosis. Clinical Neurology and Neurosurgery. 232. 107899–107899. 6 indexed citations
7.
Qin, Mingze, Yangyang Meng, Lei Liu, et al.. (2021). Discovery of 4-Arylindolines Containing a Thiazole Moiety as Potential Antitumor Agents Inhibiting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction. Journal of Medicinal Chemistry. 64(9). 5519–5534. 46 indexed citations
8.
Wang, Lihui, Zhiguo Wang, & Junping Liu. (2021). Identification of peptidomimetic telomere dysfunction inhibitor (TELODIN) through telomere dysfunction-induced foci (TIF) assay. STAR Protocols. 2(3). 100620–100620. 5 indexed citations
9.
Li, Hong, Jingyu Wang, Chunfu Wu, et al.. (2020). The combination of disulfiram and copper for cancer treatment. Drug Discovery Today. 25(6). 1099–1108. 139 indexed citations
10.
Wang, Lihui, et al.. (2020). Honokiol inhibits inflammation and endoplasmic reticulum stress in a rat model of pregnancy-induced hypertension. Biotechnology & Biotechnological Equipment. 34(1). 11–17.
11.
Wu, Xi, Xue Xue, Lihui Wang, et al.. (2018). Suppressing autophagy enhances disulfiram/copper-induced apoptosis in non-small cell lung cancer. European Journal of Pharmacology. 827. 1–12. 58 indexed citations
12.
Wang, Lihui, Xiaoyu Dong, Yong Ren, et al.. (2018). Targeting EHMT2 reverses EGFR-TKI resistance in NSCLC by epigenetically regulating the PTEN/AKT signaling pathway. Cell Death and Disease. 9(2). 129–129. 63 indexed citations
13.
Wang, Lihui, et al.. (2017). Repairing effects of ICAM-1-expressing mesenchymal stem cells in mice with autoimmune thyroiditis. Experimental and Therapeutic Medicine. 13(4). 1295–1302. 21 indexed citations
14.
Wang, Nannan, Lihui Wang, Yi Li, et al.. (2017). Targeting ALDH2 with disulfiram/copper reverses the resistance of cancer cells to microtubule inhibitors. Experimental Cell Research. 362(1). 72–82. 53 indexed citations
15.
Wang, Lihui, et al.. (2016). Gender differences in the saliva of young healthy subjects before and after citric acid stimulation. Clinica Chimica Acta. 460. 142–145. 34 indexed citations
16.
Li, Yi, Lihui Wang, Fangyang Wang, et al.. (2015). Copper improves the anti-angiogenic activity of disulfiram through the EGFR/Src/VEGF pathway in gliomas. Cancer Letters. 369(1). 86–96. 79 indexed citations
17.
Hao, Donglin, et al.. (2015). Neuroprotective effects of bisperoxovanadium on cerebral ischemia by inflammation inhibition. Neuroscience Letters. 602. 120–125. 32 indexed citations
18.
Qi, Jia, Wenyan Han, Jingyu Yang, et al.. (2012). Oxytocin regulates changes of extracellular glutamate and GABA levels induced by methamphetamine in the mouse brain. Addiction Biology. 17(4). 758–769. 75 indexed citations
19.
Yang, Jingyu, Guoliang Chen, Lihui Wang, et al.. (2008). Effects of resveratrol and its derivatives on lipopolysaccharide-induced microglial activation and their structure–activity relationships. Chemico-Biological Interactions. 174(1). 51–59. 73 indexed citations
20.
Wang, Lihui. (2004). Reference value of urinary mercury of healthy adults in Shanghai. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026